juli, an AI-powered digital health platform focused on managing complex chronic conditions, has secured USD3.8 million in a seed funding round.
The round was led by Speedinvest, one of Europe’s most active early-stage venture capital firms, and Norrsken VC, a fund investing in start-ups solving the world’s biggest problems while building massive businesses.
SoftBank’s Vision Fund Emerge Program and Dieter Von Holtzbrinck Ventures also joined the financing round.
With a vision rooted in improving care for chronic conditions, the financing will enable juli to scale its commercial team across the US, conduct clinical trials of the app, and acquire additional artificial intelligence talent.
